GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order HHSN26100011UNIVERSITY OF WISCONSIN SYSTEM

Overview

Award facts

Net obligations
$1.22M
$1,219,744of $1.22M potential value
Outlays (paid to date)
$624.99K
$624.99K paid of $1.22M obligated$624,989
Period of performance
Sep 15, 2017 to Jun 30, 2023
Ended
Modifications
13
Latest action Sep 21, 2026
Contract type
Delivery order
PIID HHSN26100011

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER

Dates and value

Award date
Signed on Sep 6, 2017
Current value
$1,219,744Base and exercised options
Potential value (if all options are exercised)
$1,219,744
Parent contract vehicle
HHSN261201200033I (IDC, multiple award) — 14 orders recorded under it

Obligations by fiscal year of action

  • FY2026: -$146,434 (de-obligation)
  • FY2025: -$107,221 (de-obligation)
  • FY2023: -$4,829 (de-obligation)
  • FY2022: $296,637
  • FY2021: $107,353
  • FY2020: $107,221
  • FY2019: $409,406
  • FY2018: $280,420
Show all 9 years
  • FY2017: $277,191

Total across 9 fiscal years: $1,219,744

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 21, 2026. View on USAspending · Recipient on SAM.gov

Recipient

NameUNIVERSITY OF WISCONSIN SYSTEM
LocationMADISON, WI
UEILCLSJAGTNZQ7
CAGE code09FZ2
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity
Parent companyUNIVERSITY OF WISCONSIN SYSTEM

Business types and certifications

Educational institutionU.S. government entity

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded from
National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)

Place of performance

Place of performance
Madison, Dane County, Wisconsin 53715-1218
Congressional district (place of performance)
WI-02As reported at the time of the action

Classification and competition

Classification

NAICS
541712RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Product or service (PSC)
AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
3

Solicitation and notices

Solicitation ID
N01CN0501469(as reported)

Contract details

Major program
Cancer prevention agent development program: early phase clinical research
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 6, 2017Base obligation at award: $277,191
Latest action
Sep 21, 2026 — Supplemental agreement (within scope)Modification P00013; obligation change -$146,434
Latest substantive action
Sep 21, 2026 — Supplemental agreement (within scope)Modification P00013; obligation change -$146,434
Latest funding action
Feb 14, 2025 — Funding onlyModification P00012; obligation change -$107,221; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action4
  • Change order3
  • Option exercised3
  • Funding only2
  • Supplemental agreement (within scope)1
14 actions recorded, Sep 6, 2017 to Sep 21, 2026; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$146,434
Latest action: change in base and all options
-$146,434

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Bio-basedE
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
14

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910
Treasury accounts
  • 075-2017/2017-0849-000
  • 075-2018/2018-0849-000
  • 075-2019/2019-0849-000
  • 075-2020/2020-0849-000
  • 075-2021/2021-0849-000
  • 075-2022/2022-0849-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression